See the DrugPatentWatch profile for Anagrelide
What is anagrelide used for?
Anagrelide is a prescription medicine used to reduce an abnormally high platelet count in certain myeloproliferative disorders, most notably essential thrombocythemia (ET). [1]
How does anagrelide work?
Anagrelide lowers platelet counts by affecting platelet production in the bone marrow. Clinically, it is used when platelet reduction is needed to lower risks associated with persistently elevated platelets in eligible patients with ET. [1]
How is anagrelide typically taken?
Anagrelide dosing is individualized based on the patient’s platelet response and tolerability. Treatment generally aims for the lowest dose that keeps platelet counts under control, with monitoring during therapy. [1]
What side effects do patients report or clinicians monitor?
Commonly reported side effects and monitoring focus can include cardiovascular effects (such as palpitations or changes in heart rhythm) and gastrointestinal effects, which are typical reasons dose adjustments or additional monitoring may be needed. [1]
Is anagrelide still under patent, and what’s the status for generic availability?
Patent and exclusivity details can change over time by country and formulation. For the most current patent/exclusivity information and any related updates, DrugPatentWatch.com tracks manufacturer and patent coverage for drugs and can be used as a practical reference point. [2]
Sources
[1] https://www.drugs.com/anagrelide.html
[2] https://www.drugpatentwatch.com/